Laboratory Equipment
Laboratory equipment for clinical labs and pathology groups includes a wide range of devices and instruments, some of which are familiar to the general public and some of which are highly specialized to clinical lab work.
Laboratory equipment is generally used to either perform an experiment or to take measurements and gather data. Larger or more sophisticated equipment is generally called a scientific instrument.
Such equipment includes test tubes, Folin-Wu tubes for blood glucose determination, petri dishes, beakers, flasks, Pasteur pipettes, glass slides, syringes and needles, autoclave, disposable gloves, tourniquets, microscopes, Bunsen burners, ultracentrifuge, electrophoresis apparatus, chromatography system, hematology analyzer, chemistry analyzer, semiauto analyzer, reflotron, setup for radioimmunoassay, setup for enzyme linked immunosorbant assay, (ELISA, colorimeter, burette, induction coils, cathode ray oscilloscope, recording kymograph and surface plasmon resonance equipment and various reagents.)
Other laboratory equipment might include a skin analyzer, oxygen analyzer, flouresence microscope, spectrum analyzer, and a digital pathology scanner, among many others.
At the same time, technology is advancing to the point where the capabilities of an entire laboratory can now be contained in relatively small devices. One relatively new device the size of a cola can is paired with a smartphone and can diagnose diseases like a clinical laboratory.
Another such device, marketed largely to developing countries that lack a well-developed network of clinical laboratories, is a credit-card-size anthrax detector that also works like a portable medical laboratory in the field.
In addition, research organizations, including one in the United States, one in New Zealand, and two in the U.K., have unveiled several devices that will analyze DNA in the field. Again, this line of research is of particular interest in developing countries where resources such as electricity for refrigeration are scarce. Some of the DNA testing devices will produce results in minutes to hours, eliminating the need to return to a clinical laboratory to analyze samples.
Ranging in size from little more than a pack of gum to about the size of a large brick, these devices for DNA analysis have the potential to serve as mobile medical laboratories for pathologists in the field.
New Cytology Technology Entering Study Phase
CEO SUMMARY: There’s a new contestant in the ongoing battle to win the Pap smear technology wars. Ampersand Medical Corporation, by signing a strategic alliance with AmeriPath, Inc., has signaled that it’s ready to bring its technology to market. AmeriPath will play a major role in ex…
Ortho-Clinical Diagnostics Embraces New Testing Technology
CEO SUMMARY: Despite a decade of consolidation, competition among the world’s largest diagnostics manufacturers remains intense. In response to this competition, Ortho-Clinical Diagnostics (OCD) is preparing a variety of new products and services for its clinical laboratory customers. I…
Accurate Costing of New Pap Technology Proves Interesting
CEO SUMMARY: Various new technologies intended to supplant conventional Pap smear screening must deliver improved clinical performance in a cost-effective manner. Joseph Plandowski, our guest writer,concludes his three-part series on new Pap smear technologies by evaluating actual lab cos…
Market Hesitates to Embrace Automated Screening Products
CEO SUMMARY: Technology to enhance and improve conventional Pap smear screening was introduced into the clinical marketplace almost five years ago. But the clinical laboratory industry has yet to embrace these various technologies in any meaningful way. Like the introduction of liquid pre…
Qualigen’s POL PSA Test Cleared for Sale by FDA
CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPack™ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…
Questions Remain About Performance Of Liquid-Prep Paps
CEO SUMMARY: During the past five years, several companies entered the lab marketplace with claims that their new Pap test technologies are improvements over conventional Pap smear methods. Armed with investment capital from Wall Street, these companies launched aggressive sales and marke…
Pap Technology Wars Expected to Intensify
CEO SUMMARY: With patience and persistence, Digene, Inc. is developing the effectiveness of its DNA-based HPV assay. Publication of recently-completed clinical trials provides evidence that Digene’s Hybrid Capture II ® HPV test, with further improvement, might become a relevant tool in…
Quantum Dots Targeting Multiplexed Bioassays
CEO SUMMARY: Here’s another exciting new technology which promises to expand the capabilities of diagnostic testing while lowering laboratory costs. Based on research originally done during the 1970’s, quantum dots™ are nanometer-sized semiconductors with unique properties. Quantum …
Court Rules Against Roche In PCR/Taq Patent Dispute
DECEMBER 7, 1999 WAS NOT an auspicious day for Hoffmann-LaRoche. One of its patents related to the PCR testing process was ruled invalid by a Federal District Court. The ruling involved Roche’s ’818 Taq patent, an enzyme used in the PCR process. The Court found that the patent h…
CARESIDE POC Solution in entirety, the traditional way of performing tests in the To Alter Lab Organization
CEO SUMMARY: CARESIDE’s point-of-care testing system gives laboratory executives a new tool for bringing value-added laboratory services to clinicians. In this exclusive interview, W. Vickery Stoughton, Chairman and CEO of CARESIDE, Inc., shares his perspectives on the clinical laborato…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.